Drug Information Related to Levobupivacaine
Back
01. Chiroscience and Maruishi to Develop Chirocaine in Japan. - Free Onlin...
LONDON--(BUSINESS WIRE)--Sept. 8, 1998--Chiroscience Group plc today
announced that it has entered into an agreement with Maruishi
Pharmaceutical Co Ltd for the development and marketing rights to its
long acting local anaesthetic, Chirocaine(R), for Japan.Under th...
02. Chiroscience and Abbott Laboratories Sign Licensing Agreement for ......
CAMBRIDGE, ENGLAND/ABBOTT PARK, Ill.--(BW HealthWire)--June 15, 1999-- Chiroscience Group plc and Abbott Laboratories announced today that the companies have signed a licensing agreement for Chiroscience's long-acting local anaesthetic Chirocaine(R) (levobupivacaine...
03. Chiroscience and Pharmacia to collaborate; Strategic alliance on ......
NEW YORK--(BUSINESS WIRE)--Sept. 18, 1995--Chiroscience Group plc, the chiral chi·rali·ty (k-rl pharmaceutical company, and Pharmacia AB, one of Europe's largest pharmaceutical companies, today jointly announced that they would collaborate on the development an...
04. Chiroscience Files Marketing Authorization Application for Chirocaine ...
LONDON--(BW HealthWire)--Dec. 4, 1997--Chiroscience Group plc today announced that it has submitted a European Marketing Authorization Application (MAA MAA - Chennai - India (Airport Code)MAA - Madras, India - Meenambarkkam (Airport Code)MAA - Maine Aquaculture Assoc...
05. Chiroscience Group plc Reports Half Year Results. - Free Online Librar...
LONDON--(BW HealthWire)--Oct. 1, 1997--Chiroscience Group plc
today announced its interim results for the six months ended August 31,
1997:Highlights:- Revenues increase by 96% to 9.2 million pounds ($14.9 million(a)),(1996: 4.7 million pounds).- ChiroTech contrib...
06. First Regulatory Approval for Chirocaine; US FDA Advisory Committee .....
LONDON--(BW HealthWire)--Dec. 16, 1998--Chiroscience Group plc, the emerging pharmaceutical company, today announced that it has achieved significant progress in gaining regulatory approval for Chirocaine, the long-acting local anaesthetic: - The Medical Products Ag...
07. Chiroscience enters joint venture on Naproxen. - Free Online Library...
NEW YORK--(BUSINESS WIRE)--Jan. 30, 1996--Chiroscience Group plc, the leading chiral chi·rali·ty (k-rl pharmaceutical company, has signed a worldwide agreement with Conti Armand de Bourbon, prince de Conti, 1629–66, son of Henry II de Condé (see un...
08. Changes in transcutaneous carbon dioxide, oxygen saturation, and ......
Background: We used transcutaneous (TC) carbon dioxide (C[O.sub.2])
monitoring to prospectively evaluate changes in respiratory status after
interscalene anesthesia in 45 adults (40 successful and 5 unsuccessful
blocks).
Methods: TC-C[O.sub.2] oxygen saturatio...
09. PDT Inc. and Pharmacia sign supply agreements. - Free Online Library...
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Sept. 13, 1995--PDT PDT - Pacific Daylight Time (GMT-0700)PDT - Pair-Wise Difference TestPDT - Partido Democrático Trabalhista (Labor Democratic Party - Brazil)PDT - Passive Doppler TrackingPDT - Passive Dual TechnologyPDT - Pe...
10. Chiroscience Group plc Reports Half Year Results | Business Wire | Fin...
LONDON--(BW HealthWire)--Oct. 1, 1997--Chiroscience Group plc today announced its interim results for the six months ended August 31, 1997:
...
11. Business outlook: Deals with big drugs players will be the key ......
Investors in biotech companies will be looking forward to a strong recovery after 1997, which was certainly a year to forget. Strangely, this contrasted sharply with the performance of the big pharmaceutical stocks, most of which advanced strongly in the hope of more...
12. First Regulatory Approval for Chirocaine; US FDA Advisory Committee .....
LONDON--(BW HealthWire)--Dec. 16, 1998--Chiroscience Group plc, the emerging pharmaceutical company, today announced that it has achieved significant progress in gaining regulatory approval for Chirocaine, the long-acting local anaesthetic:
...
